Treatment and rehabilitation for cervical cancer: the experience of patient journey management-Reference-Cited by-同舟云学术

Treatment and rehabilitation for cervical cancer: the experience of patient journey management

Published:2023-11-11 Issue:5 Volume:17 Page:625-637
ISSN:2500-3194
Container-title:Obstetrics, Gynecology and Reproduction
language:
Short-container-title:Akušerstvo, ginekologiâ i reprodukciâ

Author:

Akavova A. A.¹^ORCID,Solopova A. G.²^ORCID,Blinov D. V.³^ORCID,Achkasov E. E.²^ORCID,Galkin V. N.¹^ORCID,Korabelnikov D. I.⁴^ORCID,Mnatsakanyan A. N.⁵,Petrenko D. A.²^ORCID,Bykovshchenko G. K.²,Khazan P. L.⁶

Affiliation:

1. City Clinical Oncological Hospital No. 1

2. Sechenov University

3. Sechenov University; Institute for Preventive and Social Medicine; Moscow Haass Medical – Social Institute

4. Moscow Haass Medical – Social Institute

5. Bauman Moscow State Technical University (National Research University)

6. Lopatkin Research Institute of Urology and Interventional Radiology – Branch of National Medical Research Radiological Centre

Abstract

Radical surgical intervention, chemoradiotherapy and immune therapy implicated for patients with cervical cancer (CC) can result in significant morphofunctional, psychological, sexual disorders and social maladjustment. To optimize treatment and rehabilitation for CC patients, a routing approach has been established. This approach involves the patient's journey during diagnosis and treatment with well-defined timed stages. Additionally, a rehabilitation program with lifelong follow-up has been implemented. Prior to commencing therapy, undertaking rehabilitation after oncogynecological treatment during the stage spanning from diagnosis to therapy initiation contributes to enhancing the quality of life (QoL) for CC patients.

Publisher

IRBIS

Subject

Obstetrics and Gynecology,Embryology,Reproductive Medicine

Reference49 articles.

1. Sung H., Ferlay J., Siegel R.L. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.

2. Soerjomataram I., Bray F. Planning for tomorrow: global cancer incidence and the role of prevention 2020–2070. Nat Rev Clin Oncol. 2021;18(10):663–72. https://doi.org/10.1038/s41571-021-00514-z.

3. The state of oncological care for the Russian population in 2021. Eds. A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova. [Costoyanie onkologicheskoj pomoshchi naseleniyu Rossii v 2021 godu. Pod red. A.D. Kaprina, V.V. Starinskogo, A.O. Shahzadovoj]. Moscow: Hertsen Moscow Oncology Research Institute – Branch of National Medical Research Radiological Centre, 2022. 239 p. (In Russ.). Available at: https://oncology-association.ru/wp-content/uploads/2022/05/sostoyanie-onkologicheskoj-pomoshhinaseleniyu-rossii-v-2021-godu.pdf. [Accessed: 25.08.2023].

4. European Health Information Portal. Incidence of cervical cancer. [Evropejskij portal informacii zdravoohraneniya. Zabolevaemost' rakom shejki matki]. (In Russ.). Available at: https://gateway.euro.who.int/ru/ indicators/hfa_377-2360-incidence-of-cervix-uteri-cancer-per-100-000/?id=19308&fullGraph=true. [Accessed: 25.08.2023].

5. Clinical guidelines. Cervical cancer. [Klinicheskie rekomendacii. Rak shejki matki]. Мoscow: Ministerstvo zdravoohraneniya Rossijskoj Federacii, 2020. 66 p. (In Russ.). Available at: https://oncology-association.ru/ wp-content/uploads/2020/09/rak_shejki_matki.pdf. [Accessed: 25.08.2023].